Seipel, K., Schmitter, K., Bacher, U., & Pabst, T. (2019). Rationale for a Combination Therapy Consisting of MCL1- and MEK-Inhibitors in Acute Myeloid Leukemia. Cancers (Basel).
Styl ChicagoSeipel, Katja, Karin Schmitter, Ulrike Bacher, a Thomas Pabst. "Rationale for a Combination Therapy Consisting of MCL1- and MEK-Inhibitors in Acute Myeloid Leukemia." Cancers (Basel) 2019.
Citace podle MLASeipel, Katja, Karin Schmitter, Ulrike Bacher, a Thomas Pabst. "Rationale for a Combination Therapy Consisting of MCL1- and MEK-Inhibitors in Acute Myeloid Leukemia." Cancers (Basel) 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..